Platelet necrosis mediates ischemic stroke outcome in mice
- 6 February 2020
- journal article
- research article
- Published by American Society of Hematology in Blood
- Vol. 135 (6), 429-440
- https://doi.org/10.1182/blood.2019002124
Abstract
Dysregulated platelet functions contribute to the development and progression of ischemic stroke. Utilizing mice with a platelet-specific deletion of cyclophilin D (CypD), a mediator of necrosis, we found that platelet necrosis regulates tissue damage and outcomes during ischemic stroke in vivo. Mice with loss of CypD in platelets (CypDplt2/2mice) exhibited significantly enhanced cerebral blood flow, improved neurological and motor functions, and reduced ischemic stroke infarct volume after cerebral ischemia-reperfusion injury. These effects were attributable, at least in part, to platelet-neutrophil interactions. Twenty-four hours after stroke, significantly more circulating platelet-neutrophil aggregates (PNAs) were found in CypDplt1/1 mice. Underscoring the role of platelet necrosis in PNA formation, we observed a significant number of phosphatidylserine (PS)1 platelets in PNAs in CypDplt1/1 mice. In contrast, significantly fewer platelets in PNAs were PS1 in CypDplt2/ 2 counterparts. Accordingly, mice with CypD-deficient platelets had fewer neutrophils and PNAs recruited to their brain following stroke relative to wild-type counterparts. Neutrophil depletion in wild-type mice conferred protection from ischemic stroke to a similar degree as observed in mice with CypDdeficient platelets. Neutrophil depletion in CypDplt2/ 2 mice did not further reduce infarct size. Transmission electron microscopy of ex vivo-formed PNAs revealed a propensity of necrotic platelets to interact with neutrophils. These results suggest that necrotic platelets interact with neutrophils to exacerbate brain injury during ischemic stroke. Because inhibiting platelet necrosis does not compromise hemostasis, targeting platelet CypD may be a potential therapeutic strategy to limit brain damage following ischemic stroke.This publication has 59 references indexed in Scilit:
- All trans-retinoic acid protects against acute ischemic stroke by modulating neutrophil functions through STAT1 signalingJournal of Neuroinflammation, 2019
- TNF-alpha driven inflammation and mitochondrial dysfunction define the platelet hyperreactivity of agingBlood, 2019
- Higher Coated-Platelet Levels in Acute Stroke are Associated with Lower Cognitive Scores at Three Months Post InfarctionJournal of Stroke and Cerebrovascular Diseases, 2019
- Clots Are Potent Triggers of Inflammatory Cell Gene ExpressionArteriosclerosis, Thrombosis, and Vascular Biology, 2017
- Cyclosporine A, a Potential Therapy of Ischemic Reperfusion Injury. A Common History for Heart and BrainCerebrovascular Diseases, 2016
- Mitochondrially Mediated Integrin αIIbβ3 Protein Inactivation Limits Thrombus GrowthOnline Journal of Public Health Informatics, 2013
- Thrombin Mediates Severe Neurovascular Injury During IschemiaStroke, 2010
- Conversion of platelets from a proaggregatory to a proinflammatory adhesive phenotype: role of PAF in spatially regulating neutrophil adhesion and spreadingBlood, 2007
- Platelet Glycoprotein Ibα Is a Counterreceptor for the Leukocyte Integrin Mac-1 (Cd11b/Cd18)The Journal of Experimental Medicine, 2000
- Mice Deficient in Mac-1 (CD11b/CD18) Are Less Susceptible to Cerebral Ischemia/Reperfusion InjuryStroke, 1999